The Growth Enterprises Market (GEM) of the Hong Kong Stock Exchange (HKEX) is a dedicated platform for investing in small and medium-sized enterprises (SMEs). It operates alongside the Main Board but caters for a completely different league of companies.
While the Main Board houses established giants with long profitability records, GEM focuses on emerging enterprises and high-growth startups. For investors, Growth Enterprises Market (GEM) represents a unique frontier. It’s a place where the potential for growth is palpable, but it demands a clear understanding of its distinct risk profile.
This guide breaks down the essentials of Growth Enterprises Market (GEM) investing, from its regulatory framework and listing mechanics to a clear-eyed look at the opportunities and pitfalls it presents.
What Exactly is the Growth Enterprises Market (GEM)?
According to the Stock Exchange of Hong Kong, GEM is a market “designed to accommodate companies to which a higher investment risk may be attached than other companies listed on the Exchange”. It’s not marketing jargon, it’s regulatory fact.
It means the companies you encounter on GEM are generally smaller, less proven, and more vulnerable to business hiccups than their Main Board counterparts. As a result, GEM is explicitly “more suited to professional and other sophisticated investors.”
HKEX launched GEM on November 25, 1999, modeling it loosely after the NASDAQ in the United States. The objective was to provide a platform to support the growth of these companies, especially in technology and innovation with public funding, without the stringent profit criteria of the Main Board. Over time the board has been rebranded to suit market needs.
A Timeline of Transformation: From Steppingstone to Standalone
GEM’s history is a series of pivots. Understanding these shifts helps explain why the board looks the way it does today.
The Early 2000s
Growth Enterprises Market (GEM) quickly became a popular route for companies seeking public capital. Its lighter touch regulation attracted a wide range of businesses eager to tap into Hong Kong’s deep investor base.
The 2008 Repositioning
Officials reimagined GEM as a “steppingstone” to the Main Board. They streamlined the process for GEM-listed companies to transfer up, which led to a wave of migrations as successful firms graduated to the senior league.
The 2018 Overhaul
Having learnt from experience, HKEX determined the stepping-stone model had been “heavily exploited by lower quality companies to gain easier access to the Main Board via GEM.” The response was decisive. In 2018, regulators scrapped the streamlined transfer mechanism and repositioned GEM as “a standalone market for small and mid-sized companies.” The names “Growth Enterprise Market” and its Chinese equivalent were unified to simply “GEM.” GEM was no longer a stepping-stone to the Main Board.
Post-2018 Challenges
The tightening of rules, while necessary for market quality, had side effects. The number of new listings on GEM dried up dramatically. In the year leading up to September 2024, GEM recorded zero new IPOs. This stark statistic captured the attention of policymakers, investors, and the business community alike.
The Listing Rulebook: How Companies Qualify for GEM
If a company wants to list on GEM today, it must meet a specific set of financial and governance standards. These are lighter than the Main Board’s requirements but are by no means trivial.
Standard Listing Requirements
A GEM applicant faces several fundamental hurdles that shape the type of company you see on the board:
- At least two years of trading history.
- Positive cash flow from operating activities of at least HK$30 million in aggregate for those two years.
- An expected market capitalization at the time of listing of at least HK$150 million.
- A minimum public float value of HK$45 million, with at least 100 public shareholders.
- Management continuity for the two full financial years leading up to listing.
- At least 25% of shares in public hands, though issuers with a market cap exceeding HK$10 billion can reduce this to 15%.
These are the minimum requirements. They are designed to ensure a company has some history, some cash generation, and enough public interest to form a liquid market.
The New Alternative Eligibility Test (2024 Reforms)
HKEX recognized that the standard cash flow test was shutting out a critical class of companies: high-growth innovators that pour money into research and development (R&D) rather than producing immediate cash flow. The 2024 reforms introduced a parallel route to listing. A company can pass the alternative test if it meets the following criteria:
- Total revenue of at least HK$100 million for the past two financial years, with an upward trend.
- R&D expenditure of at least HK$30 million in aggregate over those two years, where each year’s R&D spend accounts for at least 15% of total operating expenditure.
- A market capitalization at listing of at least HK$250 million (this is higher because these companies are less mature).
This new test marks a significant philosophical shift. By emphasizing revenue growth and R&D investment over historical profitability, HKEX opened GEM’s doors to the very type of company the board was originally created to serve.
Who Can Invest in GEM (And Who Should)
There is no legal restriction preventing retail investors from buying GEM stocks through a standard brokerage account. However, the exchange makes its expectations clear. The official position is that GEM “is a market more suited to professional and other sophisticated investors”.
It’s not about exclusion. The characteristics of GEM-listed companies create a distinct risk landscape:
- Smaller businesses with limited diversification.
- Higher susceptibility to market and economic shocks.
- Possibly more volatile share prices.
- Lower trading liquidity, which can make it harder to exit positions without moving the market.
In practice, many institutional investors and fund managers have internal mandates that restrict or prohibit GEM investments. This institutional retreat has contributed to the liquidity challenges the board has faced.
The Liquidity Question: A Critical Concern
No discussion of Growth Enterprises Market (GEM) investing is complete without addressing liquidity. The numbers paint a sobering picture. In August 2024, the entire GEM board recorded an average daily turnover of just HK$29 million. For context, that is less than the daily trading volume of a single mid-cap stock on the Hong Kong Main Board. This represents a 78.75% decline compared to the same month a year earlier.
The S&P/HKEx GEM Index, which tracks the broader performance of GEM-listed stocks, underscores the scale of the downturn. Launched with a base value of 1,000 points in February 2003, the index had collapsed to just 14.33 points by September 2024. From its 2007 peak of 1,823.74 points, the decline exceeded 99%.
The total market capitalization of all GEM-listed companies stood at HK$44.8 billion as of August 2024, down 21.76% year-on-year. With 322 listed securities on board, this works out to an average market cap of roughly HK$139 million per company.
So, what does this mean for your investments? Lack of liquidity can lock up capital. Selling even a modest position may prove difficult or force you to accept a significant discount. The bid-ask spreads on many GEM stocks are wide, and the depth of the order book is often shallow.
The Delisting Framework: A Shorter Fuse
Companies listed at GEM operate under a stricter delisting regime than Main Board firms. If a GEM-listed company has its trading suspended, it has just 12 months to resolve the underlying issues and resume trading. Failing that, HKEX will cancel its listing. Main Board issuers, by comparison, get 18 months.
Common triggers for suspension and delisting include:
- Failure to maintain a suitable public float.
- Failure to maintain sufficient operations or assets to justify continued listing.
- Failure to release financial statements in a timely manner.
- Accounting irregularities or adverse audit opinions.
The shorter remedial period means problems can escalate quickly. If a GEM company you hold runs into financial reporting trouble, you have less time to assess the situation and decide whether to hold or exit before the stock potentially becomes untradeable.
The 2024 Reform Package: What Changed and Why
HKEX launched a consultation on GEM reforms in September 2023, and the resulting changes took effect in early 2024. The package addressed the most pressing concerns raised by market participants.
The New Eligibility Test
As detailed above, the alternative revenue-R&D test gives pre-profit, high-growth companies a viable path to listing without showing positive cash flow.
The Streamlined Main Board Transfer
While GEM is now a standalone market, HKEX reintroduced a simplified mechanism for GEM companies to migrate to the Main Board. Under the new streamlined process, qualifying GEM issuers can transfer without appointing a sponsor or publishing a prospectus-level listing document. To be eligible, the company must meet all Main Board listing requirements, maintain ownership continuity, show no fundamental change in its principal business, and demonstrate compliance with a prescribed daily turnover threshold.
End Of Mandatory Quarterly Reporting
Previously, GEM-listed companies had to publish quarterly financial reports, an obligation not imposed on Main Board issuers. The reform eliminated this requirement for GEM companies, aligning their reporting cycle with the Main Board’s half-yearly schedule. This reduces the compliance burden on smaller companies, though it means investors receive less frequent updates on financial performance.
GEM Versus the Main Board: A Side-by-Side View
There are other than size differences between the boards. Understanding them helps clarify what kind of investment you’re making when you buy a GEM stock.
| GEM | Main Board | |
|---|---|---|
| Target issuer | Small and mid-sized companies; high-growth enterprises. | Established, larger companies with proven track records. |
| Profit requirement | No profit requirement. | At least HK$50 million in aggregate profit over three years. |
| Cash flow | HK$30 million aggregate (or alternative R&D test). | Sufficient to demonstrate ongoing viability. |
| Min. market cap | HK$150 million. | HK$500 million. |
| Trading record | 2 financial years. | 3 financial years. |
| Public float | HK$45 million (100 shareholders). | HK$125 million (300 shareholders). |
| Quarterly reporting | Not required (post-2024). | Not required. |
| Delisting remedial period | 12 months. | 18 months. |
| Investor profile | Suited to professional and sophisticated investors. | Open to all investor categories. |
The Main Board is built for stability and scale. GEM is built for growth, but that growth comes with a higher probability of corporate stumbles, governance challenges, and share price turbulence.
Smart Investing in GEM: What to Consider
Investing in Growth Enterprises Market (GEM) requires a more hands-on and skeptical approach than investing in Main Board blue chips. Here are practical considerations for anyone thinking about allocating capital to this market.
Scrutinize The Business Model
GEM companies are often at earlier stages of their corporate lives. Ask yourself whether the business has a realistic path to sustainable revenue and, eventually, profitability. If a company qualified under the R&D test, look at what that R&D spending has produced. Does the product pipeline justify the burn rate?
Examine The Sponsor and Auditors
The quality of a company’s professional advisors can be a telling indicator. A reputable sponsor and a Big Four auditor are not guarantees of quality, but their absence should give you pause.
Watch The Shareholder Register
With a minimum of only 100 public shareholders, ownership can be highly concentrated. A few large holders can dominate trading, making the stock vulnerable to manipulation or sudden price swings on thin volume.
Check The Cash Position
Many GEM companies burn through cash quickly. Review the balance sheet to understand how long the company can operate before needing to raise fresh funds. Dilutive placements or rights issues are common in the small-cap world and can erode existing shareholder value.
Stay Alert to Delisting Risks
The 12-month delisting clock means that any trading suspension demands immediate attention. If a company misses a results deadline or has its auditor raise concerns, the timeline for resolution is short and unforgiving.
Size Positions Appropriately
Given the liquidity constraints and risk profile, any GEM investment should occupy a modest, carefully controlled place within a broader portfolio. GEM is not a market for core retirement holdings.
The Road Ahead: Rethinking GEM’s Identity
Market participants and commentators have raised fundamental questions about GEM’s future. One report described GEM as having the most liquidity crisis in its history and that the board would only have one out if it did not reform. The prescription from many observers centers on attracting genuinely high-quality companies with differentiated business models.
Some proposals suggest that applying the Main Board’s Chapter 18A biotech listing framework to GEM could inject vitality into the market. Others point to dual class share structures or companies in artificial intelligence as potential catalysts. The common thread is this: GEM needs issuers that excite institutional investors enough to bring capital back to the board.
The 2024 reforms represent a meaningful step. The R&D-focused listing route aligns GEM more closely with the innovation economy. The streamlined transfer mechanism restores a degree of the steppingstone function without the abuses of the earlier era. Yet sustained recovery will depend on whether these changes prove sufficient to attract a new generation of high-caliber companies to the board.
Conclusion
The Growth Enterprises Market offers a genuine alternative venue for companies that are too small or too early in their development for the Main Board. For investors, it provides exposure to a segment of Hong Kong’s capital markets that sits closer to the entrepreneurial frontier. That proximity to early-stage growth is precisely what makes it both potentially rewarding and inherently riskier.
The lower liquidity, shorter delisting fuse, and higher volatility are features of the landscape, not bugs to be ignored. Approaching GEM with clear eyes, disciplined position sizing, and a commitment to thorough analysis is the only sensible way to engage with this corner of the market.
The reforms of 2024 have reshaped the playing field. Whether investors and companies respond in sufficient numbers remains an open question that the next few years will answer.
Frequently Asked Questions
What is the difference between GEM and the Main Board?
GEM serves small and mid-sized companies with lighter listing requirements, while the Main Board caters to larger, more established companies with stricter financial criteria. GEM requires no profit, has a lower market capitalization threshold, and is officially positioned for professional and sophisticated investors.
Can retail investors buy GEM stocks?
Yes. There is no legal restriction preventing retail investors from buying shares listed on GEM through a standard Hong Kong brokerage account. However, the exchange explicitly warns that GEM carries higher investment risk and is more suited to professional and sophisticated investors.
Why did GEM listings decline so sharply?
The 2018 reforms eliminated the streamlined transfer mechanism to the Main Board, raised financial entry requirements, and increased minimum market capitalization and public float thresholds. These changes improved market quality but also made GEM less attractive as a listing venue. Combined with competition from alternative SME listing platforms in mainland China and a broader market downturn, new IPO activity collapsed.
What happens if a GEM company gets suspended?
A suspended GEM-listed company has 12 months to remedy the issue that caused the suspension and resume trading. If it fails to do so, HKEX will cancel its listing. This is a shorter window than the 18 months allowed for Main Board issuers.
What did the 2024 GEM reforms change?
The 2024 reforms introduced a new alternative eligibility test based on revenue and R&D expenditure, allowing pre-profit high-growth companies to list. They also reintroduced a streamlined mechanism for GEM companies to transfer to the Main Board and eliminated mandatory quarterly reporting for GEM issuers.
